<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Urinary tract infections in children: Epidemiology and risk factors</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Urinary tract infections in children: Epidemiology and risk factors</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Urinary tract infections in children: Epidemiology and risk factors</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nader Shaikh, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alejandro Hoberman, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Morven S Edwards, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Tej K Mattoo, MD, DCH, FRCP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Diane Blake, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 02, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Urinary tract infection (UTI) is a common and important clinical problem in childhood. Upper UTIs (ie, acute pyelonephritis) may lead to renal scarring, hypertension, and end-stage kidney disease. Although children with pyelonephritis tend to present with fever, it is often difficult on clinical grounds to distinguish cystitis from pyelonephritis, particularly in young children (those younger than two years) [<a href="#rid1">1</a>]. Thus, we have defined UTI broadly here without attempting to distinguish cystitis from pyelonephritis. Acute cystitis in older children is discussed separately. (See  <a class="medical medical_review" href="/d/html/6012.html" rel="external">"Acute infectious cystitis: Clinical features and diagnosis in children older than two years and adolescents"</a>.)</p><p>The presence of risk factors for UTI and renal scarring in a child presenting with fever and/or urinary symptoms is helpful in guiding diagnostic testing and management. The epidemiology and risk factors for UTI and renal scarring in children will be reviewed here. Clinical features, diagnosis, and management of UTI, and UTI in newborns (younger than one month of age) are discussed separately. (See  <a class="medical medical_review" href="/d/html/5990.html" rel="external">"Urinary tract infections in infants and children older than one month: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/5991.html" rel="external">"Urinary tract infections in infants older than one month and children less than two years: Acute management, imaging, and prognosis"</a> and  <a class="medical medical_review" href="/d/html/6066.html" rel="external">"Urinary tract infections in children: Long-term management and prevention"</a> and  <a class="medical medical_review" href="/d/html/4959.html" rel="external">"Urinary tract infections in neonates"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span></p><p class="headingAnchor" id="H3"><span class="h2">Prevalence</span><span class="headingEndMark"> — </span>Awareness of the prevalence of UTI in various subgroups of children enables the clinician to grossly estimate the probability of infection in the patient (ie, the pretest probability)  (<a class="graphic graphic_table graphicRef76804" href="/d/graphic/76804.html" rel="external">table 1</a>). This information is important in the evaluation of a child with suspected UTI. (See  <a class="medical medical_review" href="/d/html/5990.html" rel="external">"Urinary tract infections in infants and children older than one month: Clinical features and diagnosis", section on 'Decision to obtain urine sample'</a>.)</p><p class="headingAnchor" id="H4"><span class="h3">In young children with fever</span><span class="headingEndMark"> — </span>The prevalence of UTI in children &lt;2 years presenting with fever has been the subject of several large prospective studies and a meta-analysis  (<a class="graphic graphic_table graphicRef76804" href="/d/graphic/76804.html" rel="external">table 1</a>) [<a href="#rid2">2-4</a>]. Important points that emerged from these studies include:</p><p class="bulletIndent1"><span class="glyph">●</span>The overall prevalence of UTI is approximately 7 percent in febrile infants and young children but varies by age, sex, and circumcision status.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The prevalence is highest among uncircumcised males, particularly those who are younger than three months.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Females have a two- to fourfold higher prevalence of UTI than do circumcised males.</p><p></p><p>For children age 2 through 23 months of age, the probability of UTI can be estimated on a case-by-case basis using an online calculator from the University of Pittsburgh (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Futicalc.pitt.edu%2F&amp;token=fJPc4D%2B6FPiw2zr3kZ8ezxQhyrDbjDQ%2FfnkzPcR46Sic5BkZEeirTokBk5P30uE2&amp;TOPIC_ID=5988" target="_blank">UTICalc</a>) [<a href="#rid5">5,6</a>].</p><p class="headingAnchor" id="H5"><span class="h3">In older children</span><span class="headingEndMark"> — </span>In pooled analysis of four studies that included children &lt;19 years (most of whom were older than two years) and had urinary symptoms and/or fever, the prevalence of UTI was 7.8 percent (95% CI 6.6-8.9) [<a href="#rid4">4</a>].</p><p class="headingAnchor" id="H6"><span class="h1">MICROBIOLOGY</span><span class="headingEndMark"> — </span><em>Escherichia coli</em> is the most common bacterial cause of UTI; it accounts for approximately 80 percent of UTI in children [<a href="#rid7">7</a>]. Other gram-negative bacterial pathogens include <em>Klebsiella</em>, <em>Proteus</em>, <em>Enterobacter</em>, and <em>Citrobacter</em>. Gram-positive bacterial pathogens include <em>Staphylococcus saprophyticus</em>, <em>Enterococcus</em>, and, rarely, <em>Staphylococcus aureus</em>.</p><p>Infection with an organism other than <em>E. coli</em> is associated with a higher likelihood of renal scarring. In a meta-analysis of individual patient data from nine studies including 1280 children (0 to 18 years) who underwent renal scintigraphy at least five months after their first UTI, non-<em>E. coli</em> UTI was associated with an increased risk of renal scarring (odds ratio 2.2, 95% CI 1.3-3.6) [<a href="#rid8">8</a>].</p><p>The inflammatory response, as measured by the white cell count, appears to differ according to the pathogen. In a retrospective review of 1181 children diagnosed with UTI, children with <em>Enterococcus </em>species<em>, Klebsiella </em>species, and <em>Pseudomonas aeruginosa</em> were less likely to have pyuria than children with <em>Escherichia coli</em> (odds ratio of 0.14, 0.34, and 0.19, respectively) [<a href="#rid9">9</a>]. </p><p>Viruses (eg, adenovirus, enteroviruses, Coxsackieviruses, echoviruses) and fungi (eg, <em>Candida</em> spp, <em>Aspergillus</em> spp, <em>Cryptococcus neoformans</em>, endemic mycoses) are uncommon causes of UTI in children [<a href="#rid10">10,11</a>]. Viral UTI are usually limited to the lower urinary tract. Risk factors for fungal UTI include immunosuppression and long-term use of broad-spectrum antibiotic therapy, and indwelling urinary catheter [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/d/html/6012.html" rel="external">"Acute infectious cystitis: Clinical features and diagnosis in children older than two years and adolescents", section on 'Microbiology'</a>.)</p><p class="headingAnchor" id="H7"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The bacteriology of UTI, along with the observation that a minority (4 to 9 percent) of children with UTI are bacteremic [<a href="#rid13">13,14</a>], is consistent with the hypothesis that most UTI beyond the newborn period are the result of ascending infection.</p><p>Colonization of the periurethral area by uropathogenic enteric pathogens is the first step in the development of a UTI. The presence of pathogens on the periurethral mucosa, however, is not sufficient to cause UTI [<a href="#rid15">15</a>]. Pathogens attach to the uroepithelial cells via an active process mediated by glycosphingolipid receptors on the surface of epithelial cells [<a href="#rid16">16-18</a>]. Bacterial attachment recruits toll-like receptors (TLR), a family of transmembrane coreceptors involved in the recognition of pathogen-associated protein patterns [<a href="#rid18">18</a>]. TLR binding triggers a cytokine response, which generates a local inflammatory response.</p><p>A variety of virulence factors enable bacteria to ascend into the bladder and kidney. The best-studied virulence factors in <em>E. coli</em> are pili, hair-like appendages on the cell surface. Bacteria possessing pili can adhere effectively to the uroepithelium and ascend into the kidney, even in children without vesicoureteral reflux. In the kidney, the bacterial inoculum generates an intense inflammatory response, which may ultimately lead to renal scarring. (See  <a class="medical medical_review" href="/d/html/8055.html" rel="external">"Bacterial adherence and other virulence factors for urinary tract infection"</a>.)</p><p class="headingAnchor" id="H8"><span class="h1">HOST FACTORS</span><span class="headingEndMark"> — </span>A variety of host factors influence the predisposition to UTI in children.</p><p class="headingAnchor" id="H9"><span class="h2">Age</span><span class="headingEndMark"> — </span>The prevalence of UTI is highest in males younger than one year and females younger than four years [<a href="#rid4">4,19</a>].</p><p class="headingAnchor" id="H10"><span class="h2">Lack of circumcision</span><span class="headingEndMark"> — </span>Uncircumcised male infants with fever have a four- to eightfold higher prevalence of UTI than circumcised male infants [<a href="#rid4">4,20</a>]. (See <a class="local">'Prevalence'</a> above.)</p><p>Two plausible mechanisms have been proposed to explain this difference:</p><p class="bulletIndent1"><span class="glyph">●</span>The mucosal surface of the uncircumcised foreskin is more likely to bind uropathogenic bacterial species than keratinized skin on a circumcised penis [<a href="#rid21">21</a>]. The keratinization of the mucosa is largely complete by one year of age and temporally coincides with the decreasing prevalence of UTI in males.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Partial obstruction of the urethral meatus by a tight foreskin may be the explanation for the higher incidence of UTI in uncircumcised males [<a href="#rid22">22,23</a>]. In one study of uncircumcised male infants (&lt;7 months of age), inability to retract the foreskin to expose the urethral meatus was more common among males with febrile UTI than among those without UTI (85 versus 42 percent) [<a href="#rid22">22</a>]. The tightness of the foreskin diminishes with time and is an infrequent finding after one year of age [<a href="#rid22">22</a>].</p><p></p><p>Despite the increased risk, most uncircumcised males do not develop UTI [<a href="#rid24">24</a>]. A systematic review of randomized and observational studies of circumcision for the prevention of UTI found that 111 circumcisions would be needed to prevent one UTI [<a href="#rid20">20</a>]. Sensitivity analysis of a decision model for circumcision suggested that the decision to circumcise a child hinges more heavily on the caregivers' values regarding pain than on the UTI prevalence or circumcision complication rates [<a href="#rid25">25</a>]. This observation underscores the importance of respecting caregiver values as they decide whether to circumcise their sons. (See  <a class="medical medical_review" href="/d/html/6716.html" rel="external">"Neonatal circumcision: Risks and benefits"</a>.)</p><p class="headingAnchor" id="H11"><span class="h2">Female infants</span><span class="headingEndMark"> — </span>Female infants have a two- to fourfold higher prevalence of UTI than male infants [<a href="#rid4">4</a>]. This has been presumed to be the result of the shorter female urethra. However, because the incidence of UTI in male neonates is as high, if not higher, than in female neonates, the importance of the length of the urethra in the pathogenesis of UTI has been questioned. Alternatively, the propensity of bacterial attachment to the female periurethral mucosa may account for this difference.</p><p class="headingAnchor" id="H13"><span class="h2">Genetic factors</span><span class="headingEndMark"> — </span>First-degree relatives of children with UTI are more likely to have UTI than individuals without such a history [<a href="#rid26">26,27</a>]. Adherence of bacteria may, in part, be genetically determined. As an example, uroepithelial cells of females who are nonsecretors of blood group antigens have enhanced adherence of uropathogenic <em>E. coli </em>[<a href="#rid28">28,29</a>]. Genetic factors also may affect the density of <em>E. coli</em> receptors in the periurethral area and the ability to mount an inflammatory response [<a href="#rid30">30,31</a>]. (See  <a class="medical medical_review" href="/d/html/8055.html" rel="external">"Bacterial adherence and other virulence factors for urinary tract infection"</a> and  <a class="medical medical_review" href="/d/html/8053.html" rel="external">"Recurrent simple cystitis in women", section on 'Risk factors'</a>.)</p><p class="headingAnchor" id="H14"><span class="h2">Urinary obstruction</span><span class="headingEndMark"> — </span>Children with obstructive urologic abnormalities are at increased risk of developing UTI; stagnant urine is an excellent culture medium for most uropathogens. Predisposing obstructive abnormalities include the following:</p><p class="bulletIndent1"><span class="glyph">●</span>Anatomic conditions (eg, posterior urethral valves, ureteropelvic junction obstruction) (see  <a class="medical medical_review" href="/d/html/6575.html" rel="external">"Clinical presentation and diagnosis of posterior urethral valves"</a> and  <a class="medical medical_review" href="/d/html/6585.html" rel="external">"Congenital ureteropelvic junction obstruction"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Neurologic conditions (eg, myelomeningocele with neurogenic bladder) (see  <a class="medical medical_review" href="/d/html/6209.html" rel="external">"Myelomeningocele (spina bifida): Urinary tract complications"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Functional conditions (eg, bladder and bowel dysfunction) (see  <a class="medical medical_review" href="/d/html/6580.html" rel="external">"Etiology and clinical features of bladder dysfunction in children"</a> and  <a class="medical medical_review" href="/d/html/6577.html" rel="external">"Evaluation and diagnosis of bladder dysfunction in children"</a> and  <a class="medical medical_review" href="/d/html/99538.html" rel="external">"Functional constipation in infants, children, and adolescents: Clinical features and diagnosis"</a>)</p><p></p><p>Despite the increased risk of UTI in children with obstructive abnormalities, obstructive anatomic abnormalities are infrequent in children presenting with a first UTI (1 to 4 percent) [<a href="#rid1">1,32-35</a>]. Urinary obstruction should be suspected when the patient has voiding problems (eg, daytime enuresis, dribbling of urine), when other family members have had urologic abnormalities, when genitourinary abnormalities are detected on physical examination, or when symptoms do not respond to appropriate therapy.</p><p class="headingAnchor" id="H15"><span class="h2">Bladder and bowel dysfunction</span><span class="headingEndMark"> — </span>Bladder and bowel dysfunction, of which bladder dysfunction is a subset, is characterized by [<a href="#rid36">36</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>An abnormal elimination pattern (frequent or infrequent voids, daytime wetting, urgency, infrequent stools [constipation])</p><p class="bulletIndent1"><span class="glyph">●</span>Bladder and/or bowel incontinence</p><p class="bulletIndent1"><span class="glyph">●</span>Withholding maneuvers</p><p></p><p>Bladder and bowel dysfunction usually presents in otherwise-healthy school-age children and may persist for months to years. The pathophysiology is varied but basically involves a behavioral abnormality of function of the muscles of the pelvis, bladder, and/or sphincter. Although this condition is relatively common in children, it is often underdiagnosed and undertreated by primary care clinicians [<a href="#rid37">37,38</a>]. Presenting manifestations include daytime wetting, withholding behaviors, and constipation [<a href="#rid36">36</a>].</p><p>Bladder and bowel dysfunction is an important and often overlooked factor in the pathophysiology of UTI in children [<a href="#rid37">37,38</a>]. Up to 40 percent of toilet-trained children with their first UTI and 80 percent of children with recurrent (three or more) UTI report symptoms of bladder and bowel dysfunction [<a href="#rid32">32,39-42</a>]. Bladder and bowel dysfunction is also a risk factor for persistent vesicoureteral reflux (VUR), renal scarring [<a href="#rid39">39,40,43-45</a>], and recurrent UTIs [<a href="#rid46">46,47</a>]. At baseline, bladder and bowel dysfunction was identified in 56 percent of 126 toilet-trained children (&lt;6 years of age) enrolled in the randomized intervention for VUR (RIVUR) trial comparing antibiotic prophylaxis and placebo in children with grades I to IV VUR and in 46 percent of 57 toilet-trained children without VUR observed in the Careful Urinary Tract Infection Evaluation (CUTIE) study [<a href="#rid47">47,48</a>]. In both studies, bowel and bladder dysfunction was associated with increased risk of recurrent UTIs (hazard ratio 2.07, 95% CI 1.09-3.93) [<a href="#rid47">47</a>]. (See  <a class="medical medical_review" href="/d/html/6580.html" rel="external">"Etiology and clinical features of bladder dysfunction in children"</a>.)</p><p>The clinical features and diagnosis of bowel and bladder dysfunction are discussed separately. (See  <a class="medical medical_review" href="/d/html/5906.html" rel="external">"Constipation in infants and children: Evaluation"</a> and  <a class="medical medical_review" href="/d/html/6580.html" rel="external">"Etiology and clinical features of bladder dysfunction in children"</a> and  <a class="medical medical_review" href="/d/html/6577.html" rel="external">"Evaluation and diagnosis of bladder dysfunction in children"</a>.)</p><p class="headingAnchor" id="H16"><span class="h2">Vesicoureteral reflux</span><span class="headingEndMark"> — </span>VUR is the retrograde passage of urine from the bladder into the upper urinary tract. It is the most common urologic anomaly in children. Children with VUR are at increased risk for recurrent UTI. The clinical manifestations, management, and long-term implications of VUR are discussed separately. (See  <a class="medical medical_review" href="/d/html/6094.html" rel="external">"Clinical presentation, diagnosis, and course of primary vesicoureteral reflux"</a> and  <a class="medical medical_review" href="/d/html/6095.html" rel="external">"Management of vesicoureteral reflux"</a>.)</p><p class="headingAnchor" id="H17"><span class="h2">Sexual activity</span><span class="headingEndMark"> — </span>The association between sexual intercourse and UTI in females has been well documented. (See  <a class="medical medical_review" href="/d/html/8063.html" rel="external">"Acute simple cystitis in adult and adolescent females", section on 'Epidemiology'</a>.)</p><p class="headingAnchor" id="H18"><span class="h2">Bladder catheterization</span><span class="headingEndMark"> — </span>The risk of UTI increases with increasing duration of bladder catheterization. (See  <a class="medical medical_review" href="/d/html/8054.html" rel="external">"Catheter-associated urinary tract infection in adults"</a>.)</p><p class="headingAnchor" id="H19"><span class="h1">BACTERIAL-HOST INTERACTIONS</span><span class="headingEndMark"> — </span>There is indirect evidence that alteration of the normal periurethral flora promotes attachment of pathogenic bacteria as illustrated by the following observations (see <a class="local">'Pathogenesis'</a> above):</p><p class="bulletIndent1"><span class="glyph">●</span>In one study, <em>E. coli</em> and other gram-negative uropathogenic organisms were cultured more frequently from the urethras of uncircumcised males than from those of circumcised males [<a href="#rid49">49</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a prospective study of preschool children with bacteriuria, recent treatment with antibiotics for upper respiratory infections was associated with an increased risk of febrile UTI [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The use of spermicidal condoms and spermicidal jelly with diaphragms has been independently associated with <em>E. coli</em> bacteriuria, suggesting that these agents predispose to UTI by altering the normal vaginal flora (<em>Lactobacillus</em> and <em>Corynebacterium</em> spp) [<a href="#rid50">50</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In experimental studies in monkeys, the use of beta-lactam antibiotics (eg, penicillins and cephalosporins) disturbed the normal vaginal flora and promoted <em>E. coli</em> colonization [<a href="#rid51">51</a>].</p><p></p><p class="headingAnchor" id="H20"><span class="h1">RISK FACTORS FOR RENAL SCARRING</span><span class="headingEndMark"> — </span>Renal scarring, the loss of renal parenchyma between the calyces and the renal capsule, is a potential complication of UTI. Long-term consequences of renal scarring may include hypertension, decreased renal function, proteinuria, and end-stage kidney disease.</p><p class="headingAnchor" id="H10754435"><span class="h2">General risk factors</span><span class="headingEndMark"> — </span>The development of renal scarring has been associated with the following factors, which are modifiable to some extent:</p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent febrile UTI [<a href="#rid52">52</a>] (see  <a class="medical medical_review" href="/d/html/6066.html" rel="external">"Urinary tract infections in children: Long-term management and prevention", section on 'Monitor for recurrent symptoms'</a> and  <a class="medical medical_review" href="/d/html/6066.html" rel="external">"Urinary tract infections in children: Long-term management and prevention", section on 'Prevention of recurrent UTI in children without vesicoureteral reflux'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Delay in treatment of acute infection; a delay in the treatment of febrile UTIs is associated with increased risk for renal scarring [<a href="#rid53">53</a>] (see  <a class="medical medical_review" href="/d/html/5991.html" rel="external">"Urinary tract infections in infants older than one month and children less than two years: Acute management, imaging, and prognosis", section on 'Determining need for early empiric antibiotic therapy'</a>)</p><p></p><p class="bulletIndent1">Early initiation of UTI treatment requires that the diagnosis be considered even in the absence of symptoms referable to the urinary tract (eg, in the febrile infant or young child with or without a focus of infection). (See  <a class="medical medical_review" href="/d/html/5990.html" rel="external">"Urinary tract infections in infants and children older than one month: Clinical features and diagnosis", section on 'Clinical presentation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bladder and bowel dysfunction (see  <a class="medical medical_review" href="/d/html/6066.html" rel="external">"Urinary tract infections in children: Long-term management and prevention", section on 'Identify and treat bowel and bladder dysfunction'</a>)</p><p></p><p class="bulletIndent1">Modification of bladder and bowel dysfunction requires that it be recognized; presenting symptoms include daytime wetting, withholding behaviors, and constipation [<a href="#rid36">36</a>]. (See <a class="local">'Bladder and bowel dysfunction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Obstructive urinary tract malformations (see  <a class="medical medical_review" href="/d/html/6575.html" rel="external">"Clinical presentation and diagnosis of posterior urethral valves", section on 'Chronic kidney disease'</a> and  <a class="medical medical_review" href="/d/html/6585.html" rel="external">"Congenital ureteropelvic junction obstruction", section on 'Long-term outcome'</a>)</p><p></p><p class="bulletIndent1">Obstructive urinary tract malformations generally are treated surgically. (See  <a class="medical medical_review" href="/d/html/6574.html" rel="external">"Management of posterior urethral valves"</a> and  <a class="medical medical_review" href="/d/html/6585.html" rel="external">"Congenital ureteropelvic junction obstruction", section on 'Management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vesicoureteral reflux (VUR) (see  <a class="medical medical_review" href="/d/html/6094.html" rel="external">"Clinical presentation, diagnosis, and course of primary vesicoureteral reflux", section on 'Loss of renal parenchyma'</a> and  <a class="medical medical_review" href="/d/html/6095.html" rel="external">"Management of vesicoureteral reflux"</a>)</p><p></p><p>Young age has been shown to be associated with scarring in some studies [<a href="#rid54">54-56</a>], but not in others [<a href="#rid8">8,53,57-63</a>]. In a 2014 meta-analysis, older age was associated with renal scarring [<a href="#rid8">8</a>].</p><p class="headingAnchor" id="H10754442"><span class="h2">Prediction of renal scarring after first UTI</span><span class="headingEndMark"> — </span>Predictors of renal scarring after a first UTI were investigated in a meta-analysis of individual patient data from nine studies including 1280 children (0 to 18 years) who underwent renal scintigraphy at least five months after their first UTI [<a href="#rid8">8</a>]. Renal scarring was present in 15.5 percent of children. Predictors of renal scarring included:</p><p class="bulletIndent1"><span class="glyph">●</span>VUR – VUR, especially high-grade VUR, was associated with the development of renal scars (Grade I and II [odds ratio (OR) 1.8, 95% CI 1.2-2.8] and Grade IV and V VUR [OR 22.5, 95% CI 11.3-44.8])</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abnormal renal bladder ultrasonography (RBUS; OR 3.8, 95% CI 2.6-5.5)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Elevated inflammatory markers including a C-reactive protein of &gt;40 mg/L (4 mg/dL; OR 3.0, 95% CI 2.0-4.6) or a polymorphonuclear cell count &gt;60 percent (OR 1.9, 95% CI 1.3-2.8)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Temperature ≥39°C (102.2°F) (OR 2.3, 95% CI 1.6-3.3)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>UTI caused by organism other than <em>E. coli</em> (OR 2.2, 95% CI 1.3-3.6)</p><p></p><p>Children with an abnormal RBUS finding or with a combination of high fever (≥39°C [102.2°F]) and an etiologic organism other than <em>E. coli</em> (which constituted 21.7 percent of the sample) represent a particularly high-risk group in whom the risk for renal scarring is 30.7 percent. Whether more aggressive management (eg, antibiotic prophylaxis, use of adjuvant corticosteroids [<a href="#rid64">64,65</a>], further imaging with <a class="drug drug_pediatric" data-topicid="12808" href="/d/drug information/12808.html" rel="external">dimercaptosuccinic acid</a> or VCUG, and timely treatment of recurrent UTI) reduces the risk of renal scarring requires further study.</p><p class="headingAnchor" id="H21"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/16963.html" rel="external">"Patient education: Urinary tract infections in children (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topic (see  <a class="medical medical_patient" href="/d/html/1171.html" rel="external">"Patient education: Urinary tract infections in children (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H22"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prevalence</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The prevalence of urinary tract infection (UTI) in febrile children younger than two years varies from &lt;1 to 16 percent depending upon age, sex, and circumcision status in males  (<a class="graphic graphic_table graphicRef76804" href="/d/graphic/76804.html" rel="external">table 1</a>). (See <a class="local">'In young children with fever'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The prevalence of UTI in older children with urinary tract symptoms and/or fever is approximately 8 percent. (See <a class="local">'In older children'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Microbiology</strong><em> – Escherichia coli</em> is the most common bacterial cause of UTI. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Host factors</strong> – A variety of host factors influence the predisposition to UTI in children. These include female sex, genetic factors, urinary tract anomalies, bladder and bowel dysfunction, vesicoureteral reflux (VUR), sexual activity, and bladder catheterization in addition to those mentioned above for febrile young children (eg, lack of circumcision, temperature &gt;39°C [102.2°F]). (See <a class="local">'Host factors'</a> above.)</p><p></p><p class="bulletIndent1">Bladder and bowel dysfunction is an important and often overlooked factor in the pathophysiology of UTI in children. It is characterized by an abnormal elimination pattern (frequent or infrequent voids, urgency, infrequent stools), bladder and/or bowel incontinence, and withholding maneuvers. (See <a class="local">'Bladder and bowel dysfunction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk of developing renal scarring</strong> – Children with an abnormal renal ultrasonographic finding or with a combination of high fever (≥39°C [102.2°F]) and an etiologic organism other than <em>E. coli</em> have a higher risk of developing renal scarring than children without these characteristics. (See <a class="local">'Prediction of renal scarring after first UTI'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Hoberman A, Charron M, Hickey RW, et al. Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med 2003; 348:195.</a></li><li><a class="nounderline abstract_t">Hoberman A, Chao HP, Keller DM, et al. Prevalence of urinary tract infection in febrile infants. J Pediatr 1993; 123:17.</a></li><li><a class="nounderline abstract_t">Shaw KN, Gorelick M, McGowan KL, et al. Prevalence of urinary tract infection in febrile young children in the emergency department. Pediatrics 1998; 102:e16.</a></li><li><a class="nounderline abstract_t">Shaikh N, Morone NE, Bost JE, Farrell MH. Prevalence of urinary tract infection in childhood: a meta-analysis. Pediatr Infect Dis J 2008; 27:302.</a></li><li><a class="nounderline abstract_t">Shaikh N, Hoberman A, Hum SW, et al. Development and Validation of a Calculator for Estimating the Probability of Urinary Tract Infection in Young Febrile Children. JAMA Pediatr 2018; 172:550.</a></li><li class="breakAll">UTICalc for children 2 to 23 months of age. Version 3.0. https://uticalc.pitt.edu/ (Accessed on July 22, 2021).</li><li><a class="nounderline abstract_t">Edlin RS, Shapiro DJ, Hersh AL, Copp HL. Antibiotic resistance patterns of outpatient pediatric urinary tract infections. J Urol 2013; 190:222.</a></li><li><a class="nounderline abstract_t">Shaikh N, Craig JC, Rovers MM, et al. Identification of children and adolescents at risk for renal scarring after a first urinary tract infection: a meta-analysis with individual patient data. JAMA Pediatr 2014; 168:893.</a></li><li><a class="nounderline abstract_t">Shaikh N, Shope TR, Hoberman A, et al. Association Between Uropathogen and Pyuria. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Sobel JD, Vazquez JA. Fungal infections of the urinary tract. World J Urol 1999; 17:410.</a></li><li class="breakAll">Wald ER. Cystitis and pyelonephritis. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 8th ed, Cherry JD, Harrison G, Kaplan SL, et al (Eds), Elsevier, Philadelphia 2019. p.395.</li><li><a class="nounderline abstract_t">Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000; 30:14.</a></li><li><a class="nounderline abstract_t">Smellie JM, Poulton A, Prescod NP. Retrospective study of children with renal scarring associated with reflux and urinary infection. BMJ 1994; 308:1193.</a></li><li><a class="nounderline abstract_t">Hoberman A, Wald ER, Hickey RW, et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 1999; 104:79.</a></li><li><a class="nounderline abstract_t">Schlager TA, Whittam TS, Hendley JO, et al. Comparison of expression of virulence factors by Escherichia coli causing cystitis and E. coli colonizing the periurethra of healthy girls. J Infect Dis 1995; 172:772.</a></li><li><a class="nounderline abstract_t">Godaly G, Bergsten G, Hang L, et al. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol 2001; 69:899.</a></li><li><a class="nounderline abstract_t">Svanborg C, Bergsten G, Fischer H, et al. Uropathogenic Escherichia coli as a model of host-parasite interaction. Curr Opin Microbiol 2006; 9:33.</a></li><li><a class="nounderline abstract_t">Svanborg C, Frendéus B, Godaly G, et al. Toll-like receptor signaling and chemokine receptor expression influence the severity of urinary tract infection. J Infect Dis 2001; 183 Suppl 1:S61.</a></li><li><a class="nounderline abstract_t">Mårild S, Jodal U. Incidence rate of first-time symptomatic urinary tract infection in children under 6 years of age. Acta Paediatr 1998; 87:549.</a></li><li><a class="nounderline abstract_t">Singh-Grewal D, Macdessi J, Craig J. Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomised trials and observational studies. Arch Dis Child 2005; 90:853.</a></li><li><a class="nounderline abstract_t">Fussell EN, Kaack MB, Cherry R, Roberts JA. Adherence of bacteria to human foreskins. J Urol 1988; 140:997.</a></li><li><a class="nounderline abstract_t">Hiraoka M, Tsukahara H, Ohshima Y, Mayumi M. Meatus tightly covered by the prepuce is associated with urinary infection. Pediatr Int 2002; 44:658.</a></li><li><a class="nounderline abstract_t">Shim YH, Lee JW, Lee SJ. The risk factors of recurrent urinary tract infection in infants with normal urinary systems. Pediatr Nephrol 2009; 24:309.</a></li><li><a class="nounderline abstract_t">American Academy of Pediatrics Task Force on Circumcision. Male circumcision. Pediatrics 2012; 130:e756.</a></li><li><a class="nounderline abstract_t">Chessare JB. Circumcision: is the risk of urinary tract infection really the pivotal issue? Clin Pediatr (Phila) 1992; 31:100.</a></li><li><a class="nounderline abstract_t">Mårild S, Wettergren B, Hellström M, et al. Bacterial virulence and inflammatory response in infants with febrile urinary tract infection or screening bacteriuria. J Pediatr 1988; 112:348.</a></li><li><a class="nounderline abstract_t">Lundstedt AC, Leijonhufvud I, Ragnarsdottir B, et al. Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J Infect Dis 2007; 195:1227.</a></li><li><a class="nounderline abstract_t">Jantausch BA, Criss VR, O'Donnell R, et al. Association of Lewis blood group phenotypes with urinary tract infection in children. J Pediatr 1994; 124:863.</a></li><li><a class="nounderline abstract_t">Sheinfeld J, Schaeffer AJ, Cordon-Cardo C, et al. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med 1989; 320:773.</a></li><li><a class="nounderline abstract_t">Ragnarsdóttir B, Samuelsson M, Gustafsson MC, et al. Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria. J Infect Dis 2007; 196:475.</a></li><li><a class="nounderline abstract_t">Haraoka M, Hang L, Frendéus B, et al. Neutrophil recruitment and resistance to urinary tract infection. J Infect Dis 1999; 180:1220.</a></li><li><a class="nounderline abstract_t">Wan J, Kaplinsky R, Greenfield S. Toilet habits of children evaluated for urinary tract infection. J Urol 1995; 154:797.</a></li><li><a class="nounderline abstract_t">Nuutinen M, Uhari M. Recurrence and follow-up after urinary tract infection under the age of 1 year. Pediatr Nephrol 2001; 16:69.</a></li><li><a class="nounderline abstract_t">Panaretto K, Craig J, Knight J, et al. Risk factors for recurrent urinary tract infection in preschool children. J Paediatr Child Health 1999; 35:454.</a></li><li><a class="nounderline abstract_t">Elo J, Tallgren LG, Sarna S, et al. The role of vesicoureteral reflux in paediatric urinary-tract infection. Scand J Urol Nephrol 1981; 15:243.</a></li><li><a class="nounderline abstract_t">Feldman AS, Bauer SB. Diagnosis and management of dysfunctional voiding. Curr Opin Pediatr 2006; 18:139.</a></li><li><a class="nounderline abstract_t">Hellström A, Hanson E, Hansson S, et al. Association between urinary symptoms at 7 years old and previous urinary tract infection. Arch Dis Child 1991; 66:232.</a></li><li><a class="nounderline abstract_t">Shaikh N, Hoberman A, Wise B, et al. Dysfunctional elimination syndrome: is it related to urinary tract infection or vesicoureteral reflux diagnosed early in life? Pediatrics 2003; 112:1134.</a></li><li><a class="nounderline abstract_t">Snodgrass W. Relationship of voiding dysfunction to urinary tract infection and vesicoureteral reflux in children. Urology 1991; 38:341.</a></li><li><a class="nounderline abstract_t">Naseer SR, Steinhardt GF. New renal scars in children with urinary tract infections, vesicoureteral reflux and voiding dysfunction: a prospective evaluation. J Urol 1997; 158:566.</a></li><li><a class="nounderline abstract_t">Mazzola BL, von Vigier RO, Marchand S, et al. Behavioral and functional abnormalities linked with recurrent urinary tract infections in girls. J Nephrol 2003; 16:133.</a></li><li><a class="nounderline abstract_t">Bulum B, Özçakar ZB, Kavaz A, et al. Lower urinary tract dysfunction is frequently seen in urinary tract infections in children and is often associated with reduced quality of life. Acta Paediatr 2014; 103:e454.</a></li><li><a class="nounderline abstract_t">van Gool JD, Hjälmås K, Tamminen-Möbius T, Olbing H. Historical clues to the complex of dysfunctional voiding, urinary tract infection and vesicoureteral reflux. The International Reflux Study in Children. J Urol 1992; 148:1699.</a></li><li><a class="nounderline abstract_t">Koff SA, Wagner TT, Jayanthi VR. The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children. J Urol 1998; 160:1019.</a></li><li><a class="nounderline abstract_t">Seruca H. Vesicoureteral reflux and voiding dysfunction: a prospective study. J Urol 1989; 142:494.</a></li><li><a class="nounderline abstract_t">RIVUR Trial Investigators, Hoberman A, Greenfield SP, et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med 2014; 370:2367.</a></li><li><a class="nounderline abstract_t">Keren R, Shaikh N, Pohl H, et al. Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring. Pediatrics 2015; 136:e13.</a></li><li><a class="nounderline abstract_t">Carpenter MA, Hoberman A, Mattoo TK, et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics 2013; 132:e34.</a></li><li><a class="nounderline abstract_t">Wiswell TE, Miller GM, Gelston HM Jr, et al. Effect of circumcision status on periurethral bacterial flora during the first year of life. J Pediatr 1988; 113:442.</a></li><li><a class="nounderline abstract_t">Hooton TM, Scholes D, Stapleton AE, et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 2000; 343:992.</a></li><li><a class="nounderline abstract_t">Winberg J, Herthelius-Elman M, Möllby R, Nord CE. Pathogenesis of urinary tract infection--experimental studies of vaginal resistance to colonization. Pediatr Nephrol 1993; 7:509.</a></li><li><a class="nounderline abstract_t">Shaikh N, Haralam MA, Kurs-Lasky M, Hoberman A. Association of Renal Scarring With Number of Febrile Urinary Tract Infections in Children. JAMA Pediatr 2019; 173:949.</a></li><li><a class="nounderline abstract_t">Shaikh N, Mattoo TK, Keren R, et al. Early Antibiotic Treatment for Pediatric Febrile Urinary Tract Infection and Renal Scarring. JAMA Pediatr 2016; 170:848.</a></li><li><a class="nounderline abstract_t">Gleeson FV, Gordon I. Imaging in urinary tract infection. Arch Dis Child 1991; 66:1282.</a></li><li><a class="nounderline abstract_t">Martinell J, Claesson I, Lidin-Janson G, Jodal U. Urinary infection, reflux and renal scarring in females continuously followed for 13-38 years. Pediatr Nephrol 1995; 9:131.</a></li><li><a class="nounderline abstract_t">Olbing H, Claësson I, Ebel KD, et al. Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5-year report of the International Reflux Study in Children (European branch). J Urol 1992; 148:1653.</a></li><li><a class="nounderline abstract_t">Ditchfield MR, Summerville D, Grimwood K, et al. Time course of transient cortical scintigraphic defects associated with acute pyelonephritis. Pediatr Radiol 2002; 32:849.</a></li><li><a class="nounderline abstract_t">Goldraich NP, Goldraich IH. Followup of conservatively treated children with high and low grade vesicoureteral reflux: a prospective study. J Urol 1992; 148:1688.</a></li><li><a class="nounderline abstract_t">Benador D, Benador N, Slosman D, et al. Are younger children at highest risk of renal sequelae after pyelonephritis? Lancet 1997; 349:17.</a></li><li><a class="nounderline abstract_t">Lin KY, Chiu NT, Chen MJ, et al. Acute pyelonephritis and sequelae of renal scar in pediatric first febrile urinary tract infection. Pediatr Nephrol 2003; 18:362.</a></li><li><a class="nounderline abstract_t">Ataei N, Madani A, Habibi R, Khorasani M. Evaluation of acute pyelonephritis with DMSA scans in children presenting after the age of 5 years. Pediatr Nephrol 2005; 20:1439.</a></li><li><a class="nounderline abstract_t">Pecile P, Miorin E, Romanello C, et al. Age-related renal parenchymal lesions in children with first febrile urinary tract infections. Pediatrics 2009; 124:23.</a></li><li><a class="nounderline abstract_t">Mattoo TK, Chesney RW, Greenfield SP, et al. Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clin J Am Soc Nephrol 2016; 11:54.</a></li><li><a class="nounderline abstract_t">Huang YY, Chen MJ, Chiu NT, et al. Adjunctive oral methylprednisolone in pediatric acute pyelonephritis alleviates renal scarring. Pediatrics 2011; 128:e496.</a></li><li><a class="nounderline abstract_t">Shaikh N, Shope TR, Hoberman A, et al. Corticosteroids to prevent kidney scarring in children with a febrile urinary tract infection: a randomized trial. Pediatr Nephrol 2020; 35:2113.</a></li></ol></div><div id="topicVersionRevision">Topic 5988 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12529459" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Imaging studies after a first febrile urinary tract infection in young children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8320616" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Prevalence of urinary tract infection in febrile infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9685461" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Prevalence of urinary tract infection in febrile young children in the emergency department.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18316994" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Prevalence of urinary tract infection in childhood: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29710324" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Development and Validation of a Calculator for Estimating the Probability of Urinary Tract Infection in Young Febrile Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29710324" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Development and Validation of a Calculator for Estimating the Probability of Urinary Tract Infection in Young Febrile Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23369720" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Antibiotic resistance patterns of outpatient pediatric urinary tract infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25089634" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Identification of children and adolescents at risk for renal scarring after a first urinary tract infection: a meta-analysis with individual patient data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27328921" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Association Between Uropathogen and Pyuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10654372" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Fungal infections of the urinary tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10654372" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Fungal infections of the urinary tract.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10619726" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8180534" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Retrospective study of children with renal scarring associated with reflux and urinary infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10390264" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Oral versus initial intravenous therapy for urinary tract infections in young febrile children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7658071" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Comparison of expression of virulence factors by Escherichia coli causing cystitis and E. coli colonizing the periurethra of healthy girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11404374" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16406777" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Uropathogenic Escherichia coli as a model of host-parasite interaction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11171017" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Toll-like receptor signaling and chemokine receptor expression influence the severity of urinary tract infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9641738" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Incidence rate of first-time symptomatic urinary tract infection in children under 6 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15890696" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Circumcision for the prevention of urinary tract infection in boys: a systematic review of randomised trials and observational studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2902235" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Adherence of bacteria to human foreskins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12421265" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Meatus tightly covered by the prepuce is associated with urinary infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18830717" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The risk factors of recurrent urinary tract infection in infants with normal urinary systems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22926175" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Male circumcision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1544271" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Circumcision: is the risk of urinary tract infection really the pivotal issue?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3279175" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Bacterial virulence and inflammatory response in infants with febrile urinary tract infection or screening bacteriuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17357062" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8201468" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Association of Lewis blood group phenotypes with urinary tract infection in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2922027" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17597463" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Reduced toll-like receptor 4 expression in children with asymptomatic bacteriuria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10479151" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Neutrophil recruitment and resistance to urinary tract infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7609183" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Toilet habits of children evaluated for urinary tract infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11198607" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Recurrence and follow-up after urinary tract infection under the age of 1 year.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10571758" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Risk factors for recurrent urinary tract infection in preschool children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7323746" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The role of vesicoureteral reflux in paediatric urinary-tract infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16601493" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Diagnosis and management of dysfunctional voiding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2001110" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Association between urinary symptoms at 7 years old and previous urinary tract infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14595058" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Dysfunctional elimination syndrome: is it related to urinary tract infection or vesicoureteral reflux diagnosed early in life?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1755143" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Relationship of voiding dysfunction to urinary tract infection and vesicoureteral reflux in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9224361" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : New renal scars in children with urinary tract infections, vesicoureteral reflux and voiding dysfunction: a prospective evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12649544" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Behavioral and functional abnormalities linked with recurrent urinary tract infections in girls.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24974882" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Lower urinary tract dysfunction is frequently seen in urinary tract infections in children and is often associated with reduced quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1433591" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Historical clues to the complex of dysfunctional voiding, urinary tract infection and vesicoureteral reflux. The International Reflux Study in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9719268" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The relationship among dysfunctional elimination syndromes, primary vesicoureteral reflux and urinary tract infections in children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2746764" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Vesicoureteral reflux and voiding dysfunction: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24795142" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Antimicrobial prophylaxis for children with vesicoureteral reflux.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26055855" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Risk Factors for Recurrent Urinary Tract Infection and Renal Scarring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23753091" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3411387" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Effect of circumcision status on periurethral bacterial flora during the first year of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11018165" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : A prospective study of asymptomatic bacteriuria in sexually active young women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8251310" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Pathogenesis of urinary tract infection--experimental studies of vaginal resistance to colonization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31381021" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Association of Renal Scarring With Number of Febrile Urinary Tract Infections in Children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27455161" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Early Antibiotic Treatment for Pediatric Febrile Urinary Tract Infection and Renal Scarring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1661570" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Imaging in urinary tract infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7794702" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Urinary infection, reflux and renal scarring in females continuously followed for 13-38 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1433582" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Renal scars and parenchymal thinning in children with vesicoureteral reflux: a 5-year report of the International Reflux Study in Children (European branch).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12447588" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Time course of transient cortical scintigraphic defects associated with acute pyelonephritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1433589" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Followup of conservatively treated children with high and low grade vesicoureteral reflux: a prospective study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8988117" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Are younger children at highest risk of renal sequelae after pyelonephritis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12700963" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Acute pyelonephritis and sequelae of renal scar in pediatric first febrile urinary tract infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16082551" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Evaluation of acute pyelonephritis with DMSA scans in children presenting after the age of 5 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19564279" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Age-related renal parenchymal lesions in children with first febrile urinary tract infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26555605" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Renal Scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21844061" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Adjunctive oral methylprednisolone in pediatric acute pyelonephritis alleviates renal scarring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32556960" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Corticosteroids to prevent kidney scarring in children with a febrile urinary tract infection: a randomized trial.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
